Barber Daniel 4
4 · Aquestive Therapeutics, Inc. · Filed Jul 17, 2026
Research Summary
AI-generated summary of this filing
Aquestive (AQST) CEO Daniel Barber Sells 25,000 Shares
What Happened
Daniel Barber, President and CEO of Aquestive Therapeutics (AQST), reported two open-market sales: 4,631 shares on 2026-07-15 at about $4.03 per share for $18,683, and 20,369 shares on 2026-07-16 at about $4.00 per share for $81,509. Combined, Barber sold 25,000 shares for approximately $100,192. These were sales (not purchases), which are often routine liquidity events rather than a company-positive signal.
Key Details
- Transaction dates and reported prices:
- 2026-07-15: 4,631 shares at ~$4.03, proceeds $18,683 (footnote F1: sales ranged $4.00–$4.04; weighted avg $4.0344).
- 2026-07-16: 20,369 shares at ~$4.00, proceeds $81,509 (footnote F2: sales ranged $4.00–$4.01; weighted avg $4.00016).
- Total shares sold: 25,000; total reported proceeds: ~$100,192.
- Filing: Form 4 filed 2026-07-17 (covers trades on 7/15–7/16); appears to be within the normal SEC reporting window.
- Shares owned after the transactions: not specified in the provided filing details.
- Footnotes: Reporting person offers to provide, on request, the number of shares sold at each separate price (per F1 and F2).
Context
These were open-market sales (transaction code S). Sales by executives can reflect routine diversification or liquidity needs; they do not by themselves indicate company performance or future guidance. No option exercises, gifts, or 10% owner transactions are reported in the provided data.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-07-15$4.03/sh−4,631$18,683→ 630,943 total - Sale
Common Stock
[F2]2026-07-16$4.00/sh−20,369$81,509→ 610,574 total
Footnotes (2)
- [F1]The reported transaction involves sale transactions from $4.00 to $4.04 per share. The weighted average price per share was $4.0344. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.
- [F2]The reported transaction involves sale transactions from $4.00 to $4.01 per share. The weighted average price per share was $4.00016. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.